Reprise Biomedical Raises $12.5 Million and Completes Spin-off From Miromatrix Medical

sourced

Via News Release

Reprise Biomedical.png“Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from Miromatrix Medical Inc.”

Sponsors